Metabolomic tissue signature in human non‐alcoholic fatty liver disease identifies protective candidate metabolites

Abstract

This first small-molecular screen of human liver tissue identified two replicated protective metabolites. Either the use of NA or targeting its regulatory pathways might be explored to treat or prevent human NAFLD.